Summary
In patients with moderate to severe CHF, enalapril improves symptoms and is well tolerated. It increases functional capacity in the form of exercise time and reduces the left ventricular dimensions. Enalapril also has favourable effects on electrolytes and, although it increases renal blood flow, it reduces the glomerular filtration rate.
Similar content being viewed by others
References
Cleland JGF, Dargie HJ, Gillen G, et al. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones and metabolic state. British Heart Journal 54: 305, 1985
Cleland JGF, Dargie HJ, Hodsman P, et al. Captopril in heart failure: a double blind study. British Heart Journal 52: 530, 1984
Cleland JGF, Dargie HJ, Gillen G, et al. Captopril in heart failure: a double-blind study of the effects on renal function. Journal of Cardiovascular Pharmacology 8: 700, 1986
Franciosa JA, Wilen M, Zieschi S, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. American Journal of Cardiology 51: 831, 1983
Hall JE, Deighton AC, Jackson TE, et al. Control of glomerular filtration rate by the renin angiotensin system. American Journal of Physiology 5: 366–372, 1977
Peach MJ. Renin angiotensin system: biochemistry and mechanism of action. Physiological Reviews 57: 313, 1977
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dargie, H.J. Effects of Enalapril on Different Aspects of the Clinical State in Congestive Heart Failure. Drugs 32 (Suppl 5), 45–49 (1986). https://doi.org/10.2165/00003495-198600325-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198600325-00007